Skip to main content

Site notifications

SODIUM OXYBATE - REACH Reach Pharmaceuticals Pty Ltd

Product name
SODIUM OXYBATE - REACH
Accepted date
Mar-2025
Active ingredients
sodium oxybate
Proposed indication
Sodium Oxybate - Reach is for the treatment of narcolepsy.
Application type
A (new medicine)
Publication date
Mar-2025
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.